 SAN DIEGO, Nov. 2, 2021 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter fiscal year 2022, ended September 30, 2021, at 4:15 p.m. EST on Tuesday, November 9, 2021. 